| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |